A multicentre, single-blind, parallel group study to confirm the non-inferiority of the GONALEF (SJ-0021) to the Fertinorm P [urofollitropin] injection for ovulation induction treatment of infertile subjects with amenorrhea I or anovulatory cycles
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 04 Jan 2008
At a glance
- Drugs Follitropin alfa; Urofollitropin
- Indications Female infertility
- Focus Therapeutic Use
- Sponsors Merck Serono
- 04 Jan 2008 Status changed from recruiting to in progress.
- 08 May 2007 New trial record.